Clinical Trial Update: Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) [Phase 1, Phase 2]

View source ↗

Summary

The document notes that Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy) is currently recruiting Phase 1/2 trials for relapsed or refractory osteosarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• Lu-TARGO (177Lu-TARGeted Osteosarcoma Therapy)

Snippet

Sponsor: Lantheus Medical Imaging | Conditions: Relapsed / Refractory Osteosarcoma | Phase 1, Phase 2 | Status: RECRUITING